Lv2
115 积分 2021-08-23 加入
AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer
4小时前
已完结
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
5小时前
已完结
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
5小时前
已完结
Generalizable AI predicts immunotherapy outcomes across cancers and treatments
5小时前
已完结
The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications
1天前
已完结
ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib
4天前
已完结
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial
1个月前
已完结
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial
2个月前
已完结
Combination of Radiotherapy and Immunotherapy in Advanced Non–Small Cell Lung Cancer
2个月前
已完结
Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
2个月前
已完结
皖公网安备34019202002308
